Treatment for BK polyomavirus infection
AssigneeAnsun Biopharma, Inc.
InventorRonald D. Moss
Life of this patent
Estimating the term…
Abstract
The present disclosure provides novel compositions and methods for treating infection by a viral pathogen, e.g., a BK or JC polyomavirus, using agents having sialidase activity. In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by a pathogen.
Claims25
A method of treating an infection by a BK polyomavirus or a BK polyomavirus-associated disorder in a subject, the method comprising administering to the subject an effective amount of a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 13 or SEQ ID NO:14.
A method of reducing the risk or severity of an infection by BK polyomavirus or a BK polyomavirus-associated disorder in a subject, the method comprising administering to the subject an effective amount of a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 13 or SEQ ID NO:14.
Dependencies are inferred from the claim text.